These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
607 related items for PubMed ID: 9512695
41. [Intra-arterial infusion of SMANCS for treatment of patients with hepatocellular carcinoma--adverse reactions and complications]. Sakaguchi T, Yoshimatsu S, Sagara K, Yamashita Y, Takahashi M. Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():64-9. PubMed ID: 9512690 [Abstract] [Full Text] [Related]
42. [A case of recurrent multiple HCC after surgical resection showing regression by two TAEs using 5-FU and zinostatin stimalamer]. Takiya S, Sawada T, Takahashi K, Tagaya T, Fukuzawa Y, Kato K, Murata K, Ikeda H. Gan To Kagaku Ryoho; 1996 Aug; 23(9):1205-8. PubMed ID: 8751812 [Abstract] [Full Text] [Related]
43. [Arterial infusion chemotherapy with SMANCS]. Nekohashi T, Maruno J, Sanjou A, Toda G. Nihon Rinsho; 2001 Oct; 59 Suppl 6():629-33. PubMed ID: 11762025 [No Abstract] [Full Text] [Related]
44. [Use of a lipid lymphographic agent, lipiodol, as a carrier of high molecular weight antitumor agent, smancs, for hepatocellular carcinoma]. Konno T, Maeda H, Yokoyama I, Iwai K, Ogata K, Tashiro S, Uemura K, Mochinaga M, Watanabe E, Nakakuma K, Morinaga T, Miyauchi Y. Gan To Kagaku Ryoho; 1982 Nov; 9(11):2005-15. PubMed ID: 6307179 [Abstract] [Full Text] [Related]
54. [Principle and therapeutic effect of lipophilic anticancer agent [SMANCS/lipiodol]: selective targeting with oily contrast medium]. Maeda H. Gan To Kagaku Ryoho; 1989 Oct; 16(10):3323-31. PubMed ID: 2552930 [Abstract] [Full Text] [Related]
55. [Accumulation of lipiodol in hepatocellular carcinoma after transarterial chemoembolization with 5 FU-lipiodol-emulsion]. Okada K, Tada I, Suzuki K, Kim YI, Kobayashi M. Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2557-61. PubMed ID: 2843123 [Abstract] [Full Text] [Related]
56. [An anaphylactic shock case after hepatic arterial infusion of zinostatin stimalamer suspension improved by anti-histaminics]. Fukuhara K, Suzuki M, Unno M, Rikiyama T, Sakamoto N, Takeuchi H, Uchiyama T, Yamaki T, Iwasashi H, Kodama H, Matsuno S. Gan To Kagaku Ryoho; 1997 Jun; 24(8):1023-6. PubMed ID: 9212813 [Abstract] [Full Text] [Related]
57. [Prevention of hepatic metastases in rabbits by administration of an oily anticancer agent into the portal vein]. Yamasaki K, Konno T, Miyauchi Y, Maeda H. Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1224-8. PubMed ID: 3034169 [Abstract] [Full Text] [Related]
58. Reduction of hepatic metastases in rabbits by administration of an oily anticancer agent into the portal vein. Yamasaki K, Konno T, Miyauchi Y, Maeda H. Cancer Res; 1987 Feb 01; 47(3):852-5. PubMed ID: 3026619 [Abstract] [Full Text] [Related]
59. [Transcatheter arterial embolization with hepatic arterial induction of endogenous TNF in hepatocellular carcinoma]. Takekoshi H, Oyama R. Gan To Kagaku Ryoho; 1989 Aug 01; 16(8 Pt 2):2845-8. PubMed ID: 2476966 [Abstract] [Full Text] [Related]
60. [Histological effect of SMANCS/LPD therapy in renal cell carcinoma]. Suzuki T, Kobayashi M, Nakamura T, Takahashi O, Imai K, Yamanaka H, Suzuki K, Konno T, Maeda H. Nihon Gan Chiryo Gakkai Shi; 1987 Oct 20; 22(9):2210-7. PubMed ID: 2833546 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]